Primary sources
Priority goes to regulators, registries, international guidance, original studies and official product documentation.
Content you can trust
Rules for analytical materials about medical AI agents, oncology pathways and clinical trials.
Priority goes to regulators, registries, international guidance, original studies and official product documentation.
We distinguish deployment facts from vendor claims, technical metrics from clinical benefit and registry presence from access or patient outcomes.
Every article is dated. Fast-changing product, study and regulatory information must be rechecked before practical use.
Materials do not provide a personal diagnosis, prescription, prognosis or recommendation to choose a provider, trial or paid service.
Reports of factual errors are accepted by email; material corrections update the date and explain the reason.
Commercial relationships, sponsorship or author participation must be disclosed. Payment must not determine the conclusion.
Tell us which passage should be checked and link to a primary source. Do not send medical documents or health data.